Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
暂无分享,去创建一个
[1] Matej Orešič,et al. The role of metabolomics in systems biology : a new vision for drug discovery and development , 2003 .
[2] I. Wilson,et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.
[3] S. Rozen,et al. Metabolomic analysis and signatures in motor neuron disease , 2005, Metabolomics.
[4] Qing Yang,et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] D. Kell. Metabolomics and systems biology: making sense of the soup. , 2004, Current opinion in microbiology.
[6] Erin E. Carlson,et al. Chemoselective probes for metabolite enrichment and profiling , 2007, Nature Methods.
[7] R. Yolken,et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.
[8] M. Wenk. The emerging field of lipidomics , 2005, Nature Reviews Drug Discovery.
[9] G. Harrigan. Metabolic profiling: pathways in drug discovery. , 2002, Drug discovery today.
[10] Douglas B. Kell,et al. A metabolome pipeline: from concept to data to knowledge , 2005, Metabolomics.
[11] C. Schmidt. Metabolomics takes its place as latest up-and-coming "omic" science. , 2004, Journal of the National Cancer Institute.
[12] I. Björkhem,et al. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.M200434-JLR200 , 2003, Journal of Lipid Research.
[13] M. Phillips,et al. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. , 2007, Schizophrenia bulletin.
[14] K. Krishnan,et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia , 2007, Molecular Psychiatry.
[15] John C Lindon,et al. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. , 2004, Journal of pharmaceutical and biomedical analysis.
[16] M. Mimmack,et al. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. , 2007, The international journal of neuropsychopharmacology.
[17] J. van der Greef,et al. The role of analytical sciences in medical systems biology. , 2004, Current opinion in chemical biology.
[18] B. Maier,et al. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. , 2005, Journal of neurotrauma.
[19] S. DeKosky. Taking the Next Steps in the Diagnosis of Alzheimer's Disease: The Use of Biomarkers , 2008, CNS Spectrums.
[20] R. Weinshilboum,et al. Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.
[21] W. Willett,et al. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome , 2006, BMC clinical pathology.
[22] W. Weckwerth,et al. Metabolomics: from pattern recognition to biological interpretation. , 2005, Drug discovery today.
[23] John E. Duda,et al. Olfactory Dysfunction in Parkinson’s Disease , 2007, Neurosignals.
[24] Oliver Fiehn,et al. Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. , 2008, Trends in analytical chemistry : TRAC.
[25] Bruce S Kristal,et al. Metabolomics: opening another window into aging. , 2005, Science of aging knowledge environment : SAGE KE.
[26] Marco Oldiges,et al. Metabolomics: current state and evolving methodologies and tools , 2007, Applied Microbiology and Biotechnology.
[27] Burkhard Morgenstern,et al. Metabolite-based clustering and visualization of mass spectrometry data using one-dimensional self-organizing maps , 2008, Algorithms for Molecular Biology.
[28] J. Lindon,et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. , 2008, Chemical research in toxicology.
[29] S. DeKosky,et al. Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders , 2003, Science.
[30] Xiaohui Fan,et al. Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods. , 2005, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.
[31] G. Curzon. Relationships between plasma, CSF and brain tryptophan. , 1979, Journal of neural transmission. Supplementum.
[32] Sunia A Trauger,et al. Correlating the Transcriptome, Proteome, and Metabolome in the Environmental Adaptation of a Hyperthermophile , 2022 .
[33] J. Soares,et al. Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders , 2008 .
[34] L. Bren. Metabolomics: working toward personalized medicine. , 2005, FDA consumer.
[35] Frederick P Roth,et al. Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.
[36] J. Klosterkötter,et al. CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis , 2007, PloS one.
[37] Mark R Viant,et al. An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model , 2005, NMR in biomedicine.
[38] Mark R. Trusheim,et al. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.
[39] J. Nicholson. Global systems biology, personalized medicine and molecular epidemiology , 2006, Molecular systems biology.
[40] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[41] B. Hammock,et al. Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.
[42] B. Puri,et al. The use of artificial neural networks to study fatty acids in neuropsychiatric disorders , 2008, BMC psychiatry.
[43] Pedro Mendes,et al. Emerging bioinformatics for the metabolome , 2002, Briefings Bioinform..
[44] H. D. Rosas,et al. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease , 2004, NeuroRX.
[45] David Borsook,et al. A role for fMRI in optimizing CNS drug development , 2006, Nature Reviews Drug Discovery.
[46] Mia K. Markey,et al. A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples , 2006, J. Biomed. Informatics.
[47] Ian D. Wilson,et al. Metabolic Phenotyping in Health and Disease , 2008, Cell.
[48] H. Reichmann,et al. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease , 2008, Journal of Neurology.
[49] A. Nobel,et al. Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .
[50] T. Raedler,et al. CSF-studies in neuropsychiatric disorders. , 2006, Neuro endocrinology letters.
[51] D. Brooks. Neuroimaging in Parkinson’s disease , 2004, NeuroRX.
[52] W. R. Wikoff,et al. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. , 2008, The Journal of clinical investigation.
[53] Nigel W. Hardy,et al. The Metabolomics Standards Initiative , 2007, Nature Biotechnology.
[54] Elaine Holmes,et al. Metabolic changes in schizophrenia and human brain evolution , 2008, Genome Biology.
[55] Alan Hutson,et al. Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics , 2005, International journal of cancer.
[56] R. Vasan,et al. Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.
[57] Daniela Berg,et al. Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease , 2008, Neurodegenerative Diseases.
[58] J. Lindon,et al. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. , 2008, Annual review of analytical chemistry.
[59] D. Wishart. Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.
[60] V. Tolstikov,et al. Probing genetic algorithms for feature selection in comprehensive metabolic profiling approach. , 2008, Rapid communications in mass spectrometry : RCM.
[61] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[62] Dominique Gauguier,et al. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models , 2007, Nature Genetics.
[63] J. Lindon,et al. Metabonomics and its role in drug development and disease diagnosis , 2004, Expert review of molecular diagnostics.
[64] Rima Kaddurah-Daouk,et al. A preliminary metabolomic analysis of older adults with and without depression , 2007, International journal of geriatric psychiatry.
[65] Nigel W. Hardy,et al. Summary recommendations for standardization and reporting of metabolic analyses , 2005, Nature Biotechnology.
[66] J. van der Greef,et al. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. , 2007, British journal of clinical pharmacology.
[67] Michael E Phelps,et al. Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.
[68] William Jagust,et al. Molecular neuroimaging in Alzheimer’s disease , 2004, NeuroRX.
[69] P. Quinn,et al. Lipidomics: practical aspects and applications. , 2008, Progress in lipid research.
[70] Vladimir Shulaev,et al. Metabolomics technology and bioinformatics , 2006, Briefings Bioinform..
[71] D. Leibfritz,et al. Visualizing metabolic changes in breast‐cancer tissue using 1H‐NMR spectroscopy and self‐organizing maps , 2003, NMR in biomedicine.
[72] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[73] Elaine Holmes,et al. Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. , 2006, Journal of proteome research.
[74] C. Champagne,et al. Nutritional effects on blood pressure. , 2007, Current opinion in lipidology.
[75] R. Kaddurah-Daouk,et al. High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors , 2007 .
[76] Warwick B Dunn,et al. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes , 2008, Physical biology.
[77] Douglas B. Kell,et al. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning , 2005, Metabolomics.
[78] K. Fassbender,et al. Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. , 2007, Clinical chemistry.
[79] Hans-Werner Mewes,et al. Bioinformatics analysis of targeted metabolomics--uncovering old and new tales of diabetic mice under medication. , 2008, Endocrinology.
[80] David S. Wishart,et al. HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..
[81] Elaine Holmes,et al. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. , 2006, Journal of proteome research.
[82] Julian L Griffin,et al. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern‐recognition 1H NMR study , 2005, NMR in biomedicine.
[83] T. Hankemeier,et al. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.
[84] W. Matson,et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.
[85] Ian J. Brown,et al. Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.
[86] M. Tewari,et al. The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative? , 2006, PLoS medicine.
[87] D. Kell. Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.
[88] E. Wolters,et al. Variability in the clinical expression of Parkinson's disease , 2008, Journal of the Neurological Sciences.
[89] M. Tewari,et al. The Clinical Applications of a Systems Approach , 2006, PLoS medicine.
[90] Ivano Bertini,et al. Evidence of different metabolic phenotypes in humans , 2008, Proceedings of the National Academy of Sciences.
[91] Yi-Zeng Liang,et al. Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDA , 2006, FEBS letters.
[92] R. Goodacre,et al. Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis , 2003, Springer US.
[93] Elaine Holmes,et al. Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia , 2006, PLoS medicine.
[94] Thomas Hummel,et al. Olfactory loss may be a first sign of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[95] Paul Sajda,et al. Machine learning for detection and diagnosis of disease. , 2006, Annual review of biomedical engineering.
[96] D. Morvan,et al. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. , 2007, Cancer research.
[97] Royston Goodacre,et al. Metabolomics: Current technologies and future trends , 2006, Proteomics.
[98] David Broadhurst,et al. Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. , 2006, Brain : a journal of neurology.
[99] Andrew Hayes,et al. Integrative investigation of metabolic and transcriptomic data , 2006, BMC Bioinformatics.
[100] J. Nicholson,et al. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. , 2003, The Analyst.